Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare
ConclusionsThis case suggests a potential influence of Th17 cells on the neutrophil recruitment and neutrophil-driven inflammatory events leading to pseudogout induced by immune checkpoint inhibitor therapy.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Arthritis | Cancer | Cancer & Oncology | Carcinoma | Colchicine | Colcrys | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma | Rheumatology